Nils Brünner

14.1k total citations · 1 hit paper
238 papers, 9.9k citations indexed

About

Nils Brünner is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Nils Brünner has authored 238 papers receiving a total of 9.9k indexed citations (citations by other indexed papers that have themselves been cited), including 141 papers in Oncology, 131 papers in Cancer Research and 68 papers in Molecular Biology. Recurrent topics in Nils Brünner's work include Protease and Inhibitor Mechanisms (105 papers), Peptidase Inhibition and Analysis (67 papers) and Blood Coagulation and Thrombosis Mechanisms (37 papers). Nils Brünner is often cited by papers focused on Protease and Inhibitor Mechanisms (105 papers), Peptidase Inhibition and Analysis (67 papers) and Blood Coagulation and Thrombosis Mechanisms (37 papers). Nils Brünner collaborates with scholars based in Denmark, United States and Germany. Nils Brünner's co-authors include Hans Jørgen Nielsen, Keld Danø, Ib Jarle Christensen, Robert Clarke, Gunilla Høyer‐Hansen, Ross W. Stephens, Ebbe Rønne, Claus Holst‐Hansen, John A. Foekens and J Grøndahl-Hansen and has published in prestigious journals such as Journal of Clinical Investigation, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

Nils Brünner

235 papers receiving 9.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization

1998 574 citations Nils Brünner et al. profile →

Peers

Countries citing papers authored by Nils Brünner

Since Specialization

Citations

This map shows the geographic impact of Nils Brünner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nils Brünner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nils Brünner more than expected).

Fields of papers citing papers by Nils Brünner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nils Brünner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nils Brünner. The network helps show where Nils Brünner may publish in the future.

Co-authorship network of co-authors of Nils Brünner

This figure shows the co-authorship network connecting the top 25 collaborators of Nils Brünner. A scholar is included among the top collaborators of Nils Brünner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nils Brünner. Nils Brünner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Red squirrel gestation length is unchanged by maternal traits, litter composition, or future food availability 2025 ·Canadian Journal of Zoology ·Nils Brünner, Robert M. R. Barclay, Andrew G. McAdam, Ben Dantzer, Stan Boutin, Jeffrey E. Lane, April Robin Martinig	0
2	Proteomic Profiling of Colorectal Adenomas Identifies a Predictive Risk Signature for Development of Metachronous Advanced Colorectal Neoplasia 2023 ·Gastroenterology ·(unknown), Thilde Terkelsen, (unknown), Fabian Coscia, Sophia Doll, Siqi Zhao, Zhaojun Zhang, Nils Brünner, Jan Lindebjerg, (unknown), Xiangdong Fang, Matthias Mann, José M.A. Moreira	18
3	Is TIMP-1 immunoreactivity alone or in combination with other markers a predictor of benefit from anthracyclines in the BR9601 adjuvant breast cancer chemotherapy trial? 2013 ·Breast Cancer Research ·Alison F. Munro, (unknown), Eva Balslev, Christopher Twelves, David Cameron, Nils Brünner, John M.S. Bartlett	3
4	TIMP1 overexpression mediates resistance of MCF-7 human breast cancer cells to fulvestrant and down-regulates progesterone receptor expression 2013 ·Tumor Biology ·(unknown), (unknown), Kirstine Belling, Sidse Ørnbjerg Würtz, Rachita Yadav, Ulrik Lademann, Olga Rigina, Khoa Nguyen, Henrik J. Ditzel, Anne E. Lykkesfeldt, Jun Wang, Henrik Bjørn Nielsen, Nils Brünner, Ramneek Gupta, Anne‐Sofie Schrohl, Jan Stenvang	16
5	Plasma TIMP-1 levels and treatment outcome in patients treated with XELOX for metastatic colorectal cancer 2010 ·Annals of Oncology ·(unknown), Camilla Qvortrup, Ib Jarle Christensen, Bengt Glimelius, Åke Berglund, Benny Vittrup Jensen, Svend Erik Nielsen, Nina Keldsen, Hans Jørgen Nielsen, Nils Brünner, Per Pfeiffer	19
6	P84-T Rapid and Individual-Specific Glycoprofiling of the Low-Abundant Plasma Protein Tissue Inhibitor of Metalloproteinases-1 2007 ·Journal of Biomolecular Techniques JBT ·Morten Thaysen‐Andersen, Ida B. Thøgersen, Ulrik Lademann, Nils Brünner, Jan J. Enghild, Peter Højrup	1
7	European Organisation for Research and Treatment of Cancer (EORTC) Pathobiology Group standard operating procedure for the preparation of human tumour tissue extracts suited for the quantitative analysis of tissue-associated biomarkers 2007 ·European Journal of Cancer ·Manfred Schmitt, Karin Mengele, (unknown), Fred C.G.J. Sweep, John A. Foekens, Nils Brünner, (unknown), (unknown), Nadia Harbeck	26
8	Tissue inhibitor of metalloproteinase‐1 levels in plasma from tumour arteries and veins of patients with rectal cancer 2007 ·Scandinavian Journal of Clinical and Laboratory Investigation ·(unknown), Jakob Lykke, Ib Jarle Christensen, Nils Brünner, Hans Jørgen Nielsen	5
9	Preoperative Concentrations of suPAR and MBL Proteins Are Associated with the Development of Pneumonia after Elective Surgery for Colorectal Cancer 2006 ·Surgical Infections ·Mads Nordahl Svendsen, Henriette Ytting, Nils Brünner, Hans Jørgen Nielsen, Ib Jarle Christensen	11
10	Malignant transformation of wild type but not plasminogen activator inhibitor-1 gene deficient fibroblasts decreases cellular sensitivity to chemotherapy mediated apoptosis 2005 ·Cancer Research ·Ulrik Lademann, Maria Unni Rømer, Nils Brünner, Peter Bjødstrup Jensen, Kenneth Francis Hofland, (unknown)	9
11	[Serological markers of colorectal cancer]. 2005 ·PubMed ·Hans Jørgen Nielsen, Ib Jarle Christensen, Nils Brünner	2
12	Estradiol Enhances Osteolytic Lesions in Mice Inoculated with Human Estrogen Receptor-Negative MDA-231 Breast Cancer Cells in vivo 2003 ·Breast Cancer Research and Treatment ·Bent Winding, (unknown), Pernille Høegh-Andersen, Nils Brünner, Niels T. Foged	7
13	Neutralization of Adrenomedullin Inhibits the Growth of Human Glioblastoma Cell Lines in Vitro and Suppresses Tumor Xenograft Growth in Vivo 2002 ·American Journal Of Pathology ·L’Houcine Ouafik, (unknown), Françoise Boudouresque, Olivier Chinot, Christine Delfino, Fréderic Fina, Vincent Vuaroqueaux, Christophe Dussert, (unknown), H. Dufour, F. Grisoli, Pierre Casellas, Nils Brünner, Pierre‐Marie Martin	108
14	Soluble vascular endothelial growth factor in various blood transfusion components 1999 ·Transfusion ·Hans Jørgen Nielsen, K. Werther, Tommie Mynster, Nils Brünner	65
15	Expression of c-ets-1 mRNA is associated with an invasive, EMT-derived phenotype in breast carcinoma cell lines 1997 ·Clinical & Experimental Metastasis ·Christine Gilles, Myriam Polette, Philippe Birembaut, Nils Brünner, Erik W. Thompson	68
16	Expression of uPA and its receptor by both neoplastic and stromal cells during xenograft invasion 1994 ·International Journal of Cancer ·John Rømer, Charles Pyke, Leif R. Lund, Jens Eriksen, Peter Kristensen, Ebbe Rønne, Gunilla Høyer‐Hansen, Keld Danø, Nils Brünner	48
17	Effect of endocrine therapy on growth of T61 human breast cancer xenografts is directly correlated to a specific down-regulation of insulin-like growth factor II (IGF-II) 1993 ·European Journal of Cancer ·Nils Brünner, Douglas Yee, Florian Kern, Marc E. Lippman, Jennifer Cullen, Mogens Spang‐Thomsen	40
18	Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines 1992 ·Journal of Cellular Physiology ·Erik W. Thompson, Soonmyoung Paik, Nils Brünner, Connie L. Sommers, Gerhard Zugmaier, Robert Clarke, Thomas B. Shima, Jeffrey A. Torri, Steven Donahue, Marc E. Lippman, George R. Martin, Robert B. Dickson	448
19	Dose-Dependent Effect of 17β-Estradiol Determined by Growth Curves and Flow Cytometric DNA Analysis of a Human Breast Carcinoma (T61) Grown in Nude Mice 1985 ·Pathobiology ·Nils Brünner, Mogens Spang‐Thomsen, Lars L. Vindeløv, Susanne Dam Nielsen, Svend A. Engelholm, Birgit Svenstrup	19
20	[Value of mammography in the diagnosis of breast cancer]. 1978 ·PubMed ·Nils Brünner, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact